Group Cognitive Behavioural Therapy for Adults With Cystic Fibrosis
Virtual, Group Adaptation of a Cystic Fibrosis (CF) Specific Cognitive Behavioural Therapy for Adults With CF: An Exploration of Effectiveness, Feasibility, and Participant Experiences.
1 other identifier
interventional
21
1 country
2
Brief Summary
The overall goal of this clinical trial is to: a) explore the feasibility, acceptability, and participant experiences with the group version of CF-CBT; b) examine the effectiveness of the virtual delivery of a group version of CF-CBT in reducing depression and anxiety symptoms, perceived stress, coping skills, and health related quality of life among adults with CF. The primary research questions is:
- How feasible and acceptable (i.e., drop out, adherence, and satisfaction) is virtual, group CF-CBT? The secondary research questions is:
- How will virtual, group CF-CBT affect depression and anxiety? The tertiary/other research questions are:
- How will virtual, group CF-CBT affect perceived stress, coping skills, and health related quality of life?
- What is the association between group cohesion and depression, anxiety, perceived stress, coping skills, and health related quality of life? Participants will:
- Complete short demographic questionnaire regarding their personal and health information.
- Complete questionnaires about symptoms of depression, anxiety, perceived stress, coping skills, and health related quality of life at pre- and post-program. An additional measure of treatment expectancy will be completed at pre-program only. At post-program only, measures of group cohesion and treatment satisfaction will be completed.
- Complete the CF-CBT online mental health program over eight weeks.
- Be invited to complete an interview about their experiences with the program. Primary outcomes will be compared to benchmark study of individual CF-CBT. Secondary outcomes (i.e., depression, anxiety) will be compared against themselves (i.e., pre- and post-group). Tertiary/other outcomes (i.e., perceived stress, coping skills, health related quality of life) will be compared against themselves (i.e., pre- and post-group). The associations between self-reported outcome measures and group cohesion will be analyzed by computing Pearson correlation coefficients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 11, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMay 1, 2026
April 1, 2026
9 months
October 11, 2024
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of virtual group CF-CBT.
Determined by rates of program completion and program satisfaction.
From recruitment to completion of treatment (8 weeks).
Feasibility of virtual, group CF-CBT.
Determined by rates of participants recruitment (i.e., how many are interested, enroll) and rates of attendance.
From recruitment to completion of treatment (8 weeks).
Participant scores on the Client Satisfaction Questionnaire (CSQ) at the end of 8 week treatment.
The CSQ measures satisfaction with a received service on an 8-item scale with items reflecting how satisfied the individual was with the service they completed. Total scores can range from a minimum score of 8 to a maximum score of 32.
Post-intervention (8 weeks)
Secondary Outcomes (2)
Change from baseline in the Patient Health Questionnaire-9 (PHQ-9) at the end of 8 week treatment.
Baseline and post-intervention (8 weeks)
Change from baseline in the Generalized Anxiety Disorder-7 (GAD-7) at the end of 8 week treatment.
Baseline and post-intervention (8 weeks)
Other Outcomes (4)
Change from baseline in the Perceived Stress Scale (PSS) at the end of 8 week treatment.
Baseline and post-intervention (8 weeks)
Change from baseline in the CF coping self-efficacy scale (CF-CSE) at the end of 8 week treatment.
Baseline and post-intervention (8 weeks)
Change from baseline in the Cystic Fibrosis Questionnaire - Revised (CFQ-R) at the end of 8 week treatment.
Baseline and post-intervention (8 weeks)
- +1 more other outcomes
Study Arms (1)
Virtual, group CF-CBT
EXPERIMENTALInterventions
Virtual, group CF-CBT is an online, tailored CBT program for adults diagnosed with CF. Participants will attend eight weekly sessions (90 minutes each) delivered online. The sessions include: Introduction to CBT; Relaxation Skills; Depression in CF: What Helps?; Adaptive Thinking Skills, Part 1; Adaptive Thinking Skills, Part 2; Taking Charge of My Health; Anxiety in CF: What Helps?; and Maintaining Positive Changes.
Eligibility Criteria
You may qualify if:
- At least 18 years of age.
- Must speak and read in English.
- Must have depression and/or anxiety scores in the mild to moderate range (as per the PHQ-9 and GAD-7) prior to study baseline.
You may not qualify if:
- Those with suicidal intent (either with or without a plan).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
St. Paul Hospital
Vancouver, British Columbia, Canada
Royal Jubilee Hospital
Victoria, British Columbia, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 11, 2024
First Posted
October 17, 2024
Study Start
October 1, 2024
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
May 1, 2026
Record last verified: 2026-04